Childhood Acute Lymphoblastic Leukemia in Complete Remission Active Not Recruiting Phase 2 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0080800 (Childhood Acute Lymphoblastic Leukemia in Complete Remission)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs